Key details
Sponsor
Skolkovo Institute of Science and Technology
Collaborators
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russia
Enrollment target
~40 participants
Primary completion
January 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
35 Years – 70 Years
Last updated February 2025